Detalhe da pesquisa
1.
Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.
Biochemistry
; 49(5): 1014-23, 2010 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19938877
2.
First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States.
Antimicrob Agents Chemother
; 54(8): 3489-92, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20479196
3.
Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.
Clin Infect Dis
; 48(6): 739-44, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19187027
4.
Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase.
Antimicrob Agents Chemother
; 53(7): 3159-61, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19414578
5.
Community-acquired extended-spectrum beta-lactamase producers, United States.
Emerg Infect Dis
; 13(7): 1121-3, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18214201